Healthcare

4 Min read

$43M raised by Clover Biopharmaceuticals in Series B Funding

Published On 05 Dec 2019 10:43 AM

SHARE THIS ARTICLE

 13698

 1696

Based in China, the global clinical-stage bio-tech company Clover Biopharmaceuticalsis focusing on innovative biologic therapies, sealed a US$ 43m (RMB 304m) Series B financing.

Lead by Delos Capital and Lapam Capital, along with some help by from Betta Capital, Sichuan Health Care Industry Fund, Beijing Zhongguancun VC and Jinlong Group, brought the combined capital rise to more than $100 million since 2016.

Continued clin....

Click here to read more

Tags : Biopharmaceuticals, Series B Funding , $43M raised, clinical-stage,

SHARE THIS ARTICLE

What are you searching for?

Healthcare

$43M raised by Clover Biopharmaceuticals in Series B Funding

Published On 05 Dec 2019 10:43 AM

Recent Posts

According to the White House, Biden was not exposed to the question regarding Israel's decision to postpone its ground invasion of Gaza.

Asia's leading graphite producer, China, will restrict exports of a crucial battery material.

Japan requests Google to reverse the names of contested islets in the East China Sea.

Israel Rectifies Greta Thunberg's Post Regarding Gaza By Stating, "Hamas Doesn't..."

"A great deal of suffering": Jews in Europe anticipate an increase in antisemitism in the wake of the Hamas attack.

Airport and Versailles evacuations are prompted by French arrests following bomb concerns.

A man who is charged with bringing firearms onto the grounds of the Wisconsin State Capitol has pleaded not guilty to the misdemeanor charge.

Jeju Shinhwa World provides customized staycations for all visitors.

The GSDF Osprey makes its maiden voyage to Okinawa.

Conflict between Israel and Hamas: India demands strict compliance with international humanitarian law

Relations between Israel and its Arab neighbors in the Middle East

Eight airports in France have received security notifications.

A prospective Biden visit to Israel is fraught with political and security obstacles.

Physicians vow to oppose the government's plan to increase medical school quotas.

The economy minister of Japan pays a visit to Yasukuni Shrine prior to the autumn festival.